FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307687730> ?p ?o ?g. }

• W4307687730 endingPage "748" @default.
• W4307687730 startingPage "731" @default.
• W4307687730 abstract "Biologic drugs have greatly improved treatment outcomes of inflammatory joint diseases, but a substantial proportion of patients either do not respond to treatment or lose response over time. Drug immunogenicity, manifested as the formation of anti-drug antibodies (ADAb), constitute a significant clinical problem. Anti-drug antibodies influence the pharmacokinetics of the drug, are associated with reduced clinical efficacy, and an increased risk of adverse events such as infusion reactions. The prevalence of ADAb differs among drugs and diseases, and the detection of ADAb also depends on the assay format. Most data exist for the tumor necrosis factor-alpha inhibitors infliximab and adalimumab, with a frequency of ADAb that ranges from 10 to 60% across studies. Measurement of ADAb and serum drug concentrations, therapeutic drug monitoring, has been suggested as a strategy to optimize therapy with biologic drugs. Although the recent randomized clinical Norwegian Drug Monitoring (NOR-DRUM) trials show promise towards a personalized medicine prescribing approach by therapeutic drug monitoring, several challenges remain. A plethora of assay formats, with widely differing properties, is currently used for measuring ADAb. Comparing results between different assays and laboratories is difficult, which complicates the development of cut-offs necessary for guidelines and the implementation of ADAb measurements in clinical practice. With the possible exception of infliximab, limited data on clinical relevance and cost effectiveness exist to support therapeutic drug monitoring as a routine clinical strategy to monitor biologic drugs in inflammatory joint diseases. The aim of this review is to provide an overview of the characteristics and prevalence of ADAb, predisposing factors to ADAb formation, commonly used assessment methods, clinical consequences of ADAb, and the potential implications of ADAb assessments for everyday treatment of inflammatory joint diseases." @default.
• W4307687730 created "2022-11-05" @default.
• W4307687730 creator A5025212259 @default.
• W4307687730 creator A5025438429 @default.
• W4307687730 creator A5033406574 @default.
• W4307687730 creator A5058070491 @default.
• W4307687730 creator A5059000621 @default.
• W4307687730 creator A5077936932 @default.
• W4307687730 date "2022-10-31" @default.
• W4307687730 modified "2023-10-06" @default.
• W4307687730 title "Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine" @default.
• W4307687730 cites W1176283365 @default.
• W4307687730 cites W1558329586 @default.
• W4307687730 cites W1561772993 @default.
• W4307687730 cites W1579633379 @default.
• W4307687730 cites W1588728586 @default.
• W4307687730 cites W1588988525 @default.
• W4307687730 cites W1869636620 @default.
• W4307687730 cites W1918195983 @default.
• W4307687730 cites W1946645875 @default.
• W4307687730 cites W1955559925 @default.
• W4307687730 cites W1970875728 @default.
• W4307687730 cites W1985763670 @default.
• W4307687730 cites W1986864699 @default.
• W4307687730 cites W1988532712 @default.
• W4307687730 cites W1991942320 @default.
• W4307687730 cites W1995228104 @default.
• W4307687730 cites W1996472975 @default.
• W4307687730 cites W2001929304 @default.
• W4307687730 cites W2006566716 @default.
• W4307687730 cites W2013754528 @default.
• W4307687730 cites W2017883234 @default.
• W4307687730 cites W2020589546 @default.
• W4307687730 cites W2021590673 @default.
• W4307687730 cites W2024363295 @default.
• W4307687730 cites W2028514817 @default.
• W4307687730 cites W2030638063 @default.
• W4307687730 cites W2046628605 @default.
• W4307687730 cites W2046811689 @default.
• W4307687730 cites W2047275628 @default.
• W4307687730 cites W2047381094 @default.
• W4307687730 cites W2049048821 @default.
• W4307687730 cites W2054738095 @default.
• W4307687730 cites W2056226680 @default.
• W4307687730 cites W2059843231 @default.
• W4307687730 cites W2062754214 @default.
• W4307687730 cites W2073739597 @default.
• W4307687730 cites W2075732524 @default.
• W4307687730 cites W2081987637 @default.
• W4307687730 cites W2084986335 @default.
• W4307687730 cites W2088517709 @default.
• W4307687730 cites W2094960644 @default.
• W4307687730 cites W2096200590 @default.
• W4307687730 cites W2096400482 @default.
• W4307687730 cites W2096545621 @default.
• W4307687730 cites W2098556604 @default.
• W4307687730 cites W2099199787 @default.
• W4307687730 cites W2101168807 @default.
• W4307687730 cites W2104131294 @default.
• W4307687730 cites W2110057439 @default.
• W4307687730 cites W2110345763 @default.
• W4307687730 cites W2110732019 @default.
• W4307687730 cites W2111046066 @default.
• W4307687730 cites W2114964760 @default.
• W4307687730 cites W2119046820 @default.
• W4307687730 cites W2119601740 @default.
• W4307687730 cites W2120312043 @default.
• W4307687730 cites W2122404129 @default.
• W4307687730 cites W2123170396 @default.
• W4307687730 cites W2123556713 @default.
• W4307687730 cites W2125889316 @default.
• W4307687730 cites W2126049604 @default.
• W4307687730 cites W2129243589 @default.
• W4307687730 cites W2130698927 @default.
• W4307687730 cites W2141395406 @default.
• W4307687730 cites W2142617751 @default.
• W4307687730 cites W2145476831 @default.
• W4307687730 cites W2147751728 @default.
• W4307687730 cites W2147810684 @default.
• W4307687730 cites W2149055576 @default.
• W4307687730 cites W2149065814 @default.
• W4307687730 cites W2151858167 @default.
• W4307687730 cites W2153600773 @default.
• W4307687730 cites W2154144521 @default.
• W4307687730 cites W2156240435 @default.
• W4307687730 cites W2163203964 @default.
• W4307687730 cites W2163817180 @default.
• W4307687730 cites W2164764408 @default.
• W4307687730 cites W2166076134 @default.
• W4307687730 cites W2167396572 @default.
• W4307687730 cites W2168814191 @default.
• W4307687730 cites W2169856473 @default.
• W4307687730 cites W2169911848 @default.
• W4307687730 cites W2179405517 @default.
• W4307687730 cites W2187675918 @default.
• W4307687730 cites W2191817542 @default.
• W4307687730 cites W2272291172 @default.
• W4307687730 cites W2293557195 @default.

• next